Online Program Home
My Program

Keyword Search

Legend:
CC = Vancouver Convention Centre   F = Fairmont Waterfront Vancouver
* = applied session       ! = JSM meeting theme

Keyword Search Criteria: Power prior returned 11 record(s)
Sunday, 07/29/2018
Designing Trials Using Bayesian Methods with Historical Controls
Michael Sonksen, Eli Lilly and Company
2:25 PM

Leveraging Existing Information in Medical Device Clinical Trials
Rajesh Nair, CDRH/FDA; Xuefeng Li, CDRH/FDA; Laura Thompson, CDRH/FDA
3:05 PM

Monday, 07/30/2018
A Propensity Score Stratified Bayesian Power Prior Approach for Incorporating Real-World Evidence in Single Group Medical Device Clinical Studies
Chenguang Wang, John Hopkins University; Ram Tiwari, Center for Devices and Radiologica Health, FDA; Lilly Yue, U.S. Food and Drug Administration; Yunling Xu, FDA/CDRH
10:55 AM

Bayesian Approach for Benefit-Risk Assessment with Examples
Ram Tiwari, Center for Devices and Radiologica Health, FDA
11:15 AM

Evaluation of Regional Efficacy Equivalence in Developing Biosimilars
Ryuji Uozumi, Kyoto University Graduate School of Medicine; Shinjo Yada, A2 Healthcare Corporation
3:20 PM

Tuesday, 07/31/2018
Bridging Information Between Dose-Response Curves Across Populations in Early Phase Clinical Trials
Moreno Ursino, Inserm DR PA 6


Bridging Information Between Dose-Response Curves Across Populations in Early Phase Clinical Trials
Moreno Ursino, Inserm DR PA 6
8:45 AM

Incorporating Historical Information into the Analysis of Clinical Trials- a Case Study
Guochen Song, Biogen; Yiqing Tian, Q2 Sulotions; John Zhong, Biogen; Stacy Lindborg, Biogen Idec
8:50 AM

Wednesday, 08/01/2018
Incorporating Design Weights and Historical Data into Model-Based Small-Area Estimation
Hui Xie, CDC; Lawrence Barker, CDC; Deborah Rolka, CDC
3:35 PM

Thursday, 08/02/2018
Variational Inference for Proportional Hazards Model with Power Prior in Oncology Studies
Bo Jin, Boston Biomedical Inc.; Yue Chang, Boston Biomedical Inc
8:35 AM

A Bayesian Approach to Benefit-Risk Assessment for Ophthalmic Devices
Chul Ahn, FDA-CDRH
12:05 PM